Education
About Us
Working with TipRanks
Follow Us
Treace Medical Concepts (TMCI)
NASDAQ:TMCI
RESEARCH TOOLSreports
TMCI Stock Chart & Stats
Day’s Range― - ―
52-Week Range$3.92 - $13.80
Previous CloseN/A
Volume76.56K
Average Volume (3M)445.55K
Market Cap
$559.81M
Enterprise Value$348.25M
Total Cash (Recent Filing)-$12.14M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta2.21
Next Earnings
May 13, 2025EPS Estimate
-0.3Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.90
Shares Outstanding62,618,725
10 Day Avg. Volume425,072
30 Day Avg. Volume445,552
Standard Deviation0.21
R-Squared0.03
Alpha-0.01
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)2.76
Price to Cash Flow (P/CF)-11.80
P/FCF Ratio0.00
Enterprise Value/Market Cap0.62
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit2.29
Enterprise Value/Ebitda-7.21
Forecast
1Y Price Target
$11.58Price Target Upside32.19% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
---
Treace Medical Concepts News
PremiumCompany Announcements
Treace Medical’s Earnings Call Highlights Growth and Innovation
PremiumCompany Announcements
Treace Medical Concepts Reports Strong 2024 Growth
PremiumCompany Announcements
Treace Medical Concepts Reports Strong 2024 Revenue Growth
---
Bulls Say, Bears Say
Bulls Say
EarningsTreace reported Q4 results slightly higher than estimates and consensus, indicating strong performance.
InnovationEarly feedback on Treace’s Nanoplasty and Percuplasty solutions is universally positive, attracting previously reluctant surgeons.
Bears Say
Growth ConcernsLapiplasty growth has stalled, raising concerns about the company's growth profile in this area.
---
Ownership Overview
30.33% Insiders
10.62% Mutual Funds
20.99% Other Institutional Investors
24.96% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
TMCI FAQ
What was Treace Medical Concepts’s price range in the past 12 months?
Treace Medical Concepts lowest stock price was $3.92 and its highest was $13.80 in the past 12 months.
What is Treace Medical Concepts’s market cap?
Treace Medical Concepts’s market cap is $559.81M.
When is Treace Medical Concepts’s upcoming earnings report date?
Treace Medical Concepts’s upcoming earnings report date is May 13, 2025 which is in 70 days.
How were Treace Medical Concepts’s earnings last quarter?
Treace Medical Concepts released its earnings results on Feb 27, 2025. The company reported -$0.01 earnings per share for the quarter, beating the consensus estimate of -$0.038 by $0.028.
Is Treace Medical Concepts overvalued?
According to Wall Street analysts Treace Medical Concepts’s price is currently Undervalued.
Does Treace Medical Concepts pay dividends?
Treace Medical Concepts does not currently pay dividends.
What is Treace Medical Concepts’s EPS estimate?
Treace Medical Concepts’s EPS estimate is -0.3.
How many shares outstanding does Treace Medical Concepts have?
Treace Medical Concepts has 62,618,725 shares outstanding.
What happened to Treace Medical Concepts’s price movement after its last earnings report?
Treace Medical Concepts reported an EPS of -$0.01 in its last earnings report, beating expectations of -$0.038. Following the earnings report the stock price went down -2.081%.
Which hedge fund is a major shareholder of Treace Medical Concepts?
Currently, no hedge funds are holding shares in TMCI
---
Treace Medical Concepts Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$11.58 (32.19% Upside)
$11.58 (32.19% Upside)
Blogger Sentiment
Bearish
TMCI Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 34.6K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ―
Last 30 Days ―
Last 30 Days ―
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-33.87%
12-Months-Change
Fundamentals
Return on Equity
-44.45%
Trailing 12-Months
Asset Growth
-13.82%
Trailing 12-Months
Company Description
Treace Medical Concepts
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly.
---
TMCI Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a generally positive outlook for Treace Medical, with strong revenue growth and successful product launches being key highlights. Although there were some financial lowlights such as a decrease in gross margin and a net loss for the year, the company's strategic initiatives and improvements in adjusted EBITDA suggest a promising trajectory.Read More>---
TMCI Stock 12 Month Forecast
Average Price Target
$11.58
▲(32.19% Upside)
Technical Analysis
Best Analysts Covering TMCI
1 Year
1 Year Success Rate
2/15 ratings generated profit
1 Year Average Return
-35.79%
reiterated a buy rating 6 days ago
Copying Ryan Zimmerman's trades and holding each position for 1 Year would result in 13.33% of your transactions generating a profit, with an average return of -35.79% per trade.
---